Tetramodality treatment of human melanoma in vitro

E. Auzenne, B. Feig, M. I. Ross, S. P. Tomasovic, J. Klostergaard

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

We evaluated the in vitro cytotoxic effects of combined human tumour necrosis factor alpha (TNF), human Interferon gamma (IFN-γ), melphalan (L-PAM) and hyperthermia (HTX) on human melanoma cell lines using the crystal violet assay. HTX (40°C, 1 h) alone had no effect. The responses of the cell lines to TNF were in the rank order of 939 cells > 987 > 284 > C8161 > 852 > A2058 ~0, and all displayed shallow dose-response curves; no significant thermal enhancement of TNF cytotoxicity was apparent with this heat dose. All cell lines were sensitive to L-PAM, with 284 cells being the most sensitive; HTX caused only slightly increased sensitization to L-PAM. The combination of TNF and L-PAM resulted in generally subadditive or additive cytotoxicity, with or without HTX. The response to IFN-γ alone was heterogeneous; the 939,284 and 852 cell lines were sensitive to a dose as low as 20 ng/ml, whereas the 987 line was resistant to 2.0 μg/ml, even with HTX. IFN-γ enhanced the response to TNF only of the TNF-resistant A2058 cell line, but there was no enhancement of the response to L-PAM for any line. Thus, this tetramodality combination achieved generally subadditive or additive cytoxicity in vitro.

Original languageEnglish (US)
Pages (from-to)49-57
Number of pages9
JournalMelanoma research
Volume5
Issue number1
DOIs
StatePublished - Feb 1995

Keywords

  • Cytotoxicity
  • Human
  • Hyperthermia
  • IFN-y
  • L-PAM
  • Melanoma
  • TNF

ASJC Scopus subject areas

  • Oncology
  • Dermatology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Tetramodality treatment of human melanoma in vitro'. Together they form a unique fingerprint.

Cite this